NCT03635567 2026-02-04KEYNOTE-826Merck Sharp & Dohme LLCPhase 3 Completed617 enrolled 29 charts 1 FDA
NCT02358031 2025-07-18MK-3475-048Merck Sharp & Dohme LLCPhase 3 Completed882 enrolled 50 charts 1 FDA
NCT02819518 2024-11-27KEYNOTE-355Merck Sharp & Dohme LLCPhase 3 Completed882 enrolled 41 charts 2 FDA
NCT02775435 2024-10-08KEYNOTE-407Merck Sharp & Dohme LLCPhase 3 Completed559 enrolled 18 charts 1 FDA